Palbociclib in combination with simvastatin induce severe rhabdomyolysis: a case report

Palbociclib in combination with simvastatin induce severe rhabdomyolysis: a case report

Abstract Background Palbociclib is a selective well-tolerated antineoplastic drug used in the treatment of advanced HER2-negative, estrogen-receptor positive breast cancer that has shown significant improvement in progression-free survival. We present a patient that developed severe rhabdomyolysis w...

Full description

Bibliographic Details
Main Authors: Vardan Nersesjan, Klaus Hansen, Thomas Krag, Morten Duno, Tina D. Jeppesen
Format: Article
Language:English
Published: BMC 2019-10-01
Series:BMC Neurology
Subjects:
Palbociclib
Simvastatin
Rhabdomyolysis
CYP3A4
rs4149056
Online Access:http://link.springer.com/article/10.1186/s12883-019-1490-4

Internet

http://link.springer.com/article/10.1186/s12883-019-1490-4

Similar Items